Clearmind Medicine Inc [NASDAQ: CMND] price plunged by -0.77 percent to reach at -$0.01. The company report on March 19, 2024 at 7:55 AM that Breakthrough in Wellness: Clearmind Medicine’s Psychedelic Treatment Granted Divisional Patent Approval in China. A Novel Approach to Combatting Binge Behaviors
Clearmind Medicine Inc [NASDAQ: CMND] stock went on an upward path that rose over 14.07% on Tuesday, amounting to a one-week price increase of more than 1.32%. The company report on February 20, 2024 at 7:14 AM that SciSparc and Clearmind Continue to Strengthen International
Clearmind Medicine Inc [NASDAQ: CMND] gained 20.28% on the last trading session, reaching $1.72 price per share at the time. The company report on February 1, 2024 at 8:15 AM that Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center. The licensing
© 2024, Powered by Smart TechOne
